Form 8-K - Current report:
SEC Accession No. 0001213900-24-090121
Filing Date
2024-10-24
Accepted
2024-10-24 07:01:37
Documents
14
Period of Report
2024-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218506-8k_incannex.htm   iXBRL 8-K 30406
2 EMPLOYMENT AGREEMENT, EFFECTIVE OCTOBER 21, 2024, BY AND BETWEEN THE COMPANY AND ea021850601ex10-1_incannex.htm EX-10.1 28500
  Complete submission text file 0001213900-24-090121.txt   244830

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ixhl-20241021.xsd EX-101.SCH 3024
4 XBRL LABEL FILE ixhl-20241021_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ixhl-20241021_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0218506-8k_incannex_htm.xml XML 3787
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 241390686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)